Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$27.10 -0.04 (-0.15%)
As of 03:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

WRBY vs. PEN, STVN, IRTC, BLCO, GKOS, TMDX, NVST, LIVN, SLNO, and INSP

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Soleno Therapeutics (SLNO), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Penumbra (NYSE:PEN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.

Penumbra currently has a consensus price target of $302.93, suggesting a potential upside of 18.98%. Warby Parker has a consensus price target of $24.06, suggesting a potential downside of 11.20%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.88
Warby Parker
0 Sell rating(s)
9 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.55

88.9% of Penumbra shares are owned by institutional investors. Comparatively, 93.2% of Warby Parker shares are owned by institutional investors. 5.0% of Penumbra shares are owned by insiders. Comparatively, 18.2% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Warby Parker had 1 more articles in the media than Penumbra. MarketBeat recorded 11 mentions for Warby Parker and 10 mentions for Penumbra. Penumbra's average media sentiment score of 1.35 beat Warby Parker's score of 0.87 indicating that Penumbra is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Penumbra
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
7 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Penumbra has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.1, suggesting that its share price is 110% more volatile than the S&P 500.

Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Penumbra$1.19B8.31$14.01M$3.7667.71
Warby Parker$771.32M3.70-$20.39M-$0.07-387.11

Penumbra has a net margin of 11.54% compared to Warby Parker's net margin of -1.12%. Penumbra's return on equity of 11.55% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Penumbra11.54% 11.55% 8.76%
Warby Parker -1.12%-0.79%-0.41%

Summary

Penumbra beats Warby Parker on 13 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.86B$33.30B$16.00B$21.44B
Dividend YieldN/A2.64%3.04%3.49%
P/E Ratio-389.0240.2018.3329.81
Price / Sales3.701.8847.8351.35
Price / Cash77.6516.3814.8324.78
Price / Book8.098.506.144.54
Net Income-$20.39M$1.23B$679.72M$999.97M
7 Day Performance0.04%-0.33%0.47%1.54%
1 Month Performance-0.52%-1.01%1.04%4.77%
1 Year Performance82.11%17.18%-1.22%14.11%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
1.5233 of 5 stars
$27.10
-0.2%
$24.06
-11.2%
+80.7%$2.86B$771.32M-389.023,780Analyst Upgrade
Insider Trade
PEN
Penumbra
4.787 of 5 stars
$263.58
-3.4%
$302.93
+14.9%
+40.2%$10.64B$1.19B70.104,500
STVN
Stevanato Group
N/A€26.21
-0.8%
N/A+42.3%€7.94B€1.19B48.545,521Positive News
IRTC
iRhythm Technologies
1.1865 of 5 stars
$176.16
-2.0%
$163.82
-7.0%
+136.6%$5.78B$657.23M-60.122,000Positive News
BLCO
Bausch + Lomb
2.1241 of 5 stars
$15.23
+0.2%
$15.56
+2.2%
-16.3%$5.38B$4.79B-19.5213,500
GKOS
Glaukos
4.6454 of 5 stars
$80.72
-2.5%
$124.83
+54.6%
-33.7%$4.75B$383.48M-48.92780Positive News
TMDX
TransMedics Group
2.7163 of 5 stars
$114.29
-0.2%
$122.11
+6.8%
-21.2%$3.91B$441.54M59.22210Analyst Forecast
NVST
Envista
3.7096 of 5 stars
$21.12
+0.5%
$20.92
-0.9%
+11.5%$3.49B$2.51B65.9912,300Positive News
Analyst Downgrade
LIVN
LivaNova
2.8818 of 5 stars
$55.43
-1.4%
$59.71
+7.7%
+12.6%$3.07B$1.25B-14.252,900Positive News
SLNO
Soleno Therapeutics
4.4506 of 5 stars
$51.17
-4.6%
$115.09
+124.9%
-5.8%$2.85BN/A-12.3630Short Interest ↑
INSP
Inspire Medical Systems
4.8968 of 5 stars
$80.90
+1.1%
$164.50
+103.3%
-61.1%$2.37B$802.80M46.761,246Positive News

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners